| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 8378- | LT, | Luteolin and its derivatives: modulation of epithelial-mesenchymal transition in fibrosis and cancer |
| - | Review, | Var, | NA |
| 8386- | LT, | Luteolin induces apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia cell by regulating the PI3K/AKT signaling pathway |
| - | in-vitro, | ALL, | SUP-B15 |
| 8366- | LT, | Preliminary Evidence on Safety and Clinical Efficacy of Luteolin for Patients With Prostate Cancer Under Active Surveillance |
| - | Trial, | Pca, | NA |
| 8368- | LT, | A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells |
| - | in-vitro, | Lung, | NA |
| - | in-vitro, | Nor, | MCF10 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | PC, | Bxpc-3 |
| 3980- | Lut, | Zeax, | Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease |
| - | Trial, | AD, | NA |
| 8357- | Lut, | Comparison of lutein bioavailability from vegetables and supplement |
| - | Study, | Nor, | NA |
| 8347- | Lut, | Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms |
| - | in-vitro, | BC, | NA |
| 8355- | Lut, | Zeax, | Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration |
| - | Trial, | AMD, | NA |
| 8412- | Lyco, | Brain-targeted lycopene-loaded microemulsion modulates neuroinflammation, oxidative stress, apoptosis and synaptic plasticity in β-amyloid-induced Alzheimer's disease mice |
| - | in-vivo, | AD, | NA |
| 7742- | Lyco, | isoFl, | Lycopene and soy isoflavones in the treatment of prostate cancer |
| - | Trial, | Pca, | NA |
| 1041- | Lyco, | immuno, | Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells |
| - | in-vivo, | Lung, | NA |
| 3281- | Lyco, | Chemo, | Lycopene Supplementation for Patients Under Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| - | Review, | Var, | NA |
| 3287- | Lyco, | Recent technological strategies for enhancing the stability of lycopene in processing and production |
| - | Review, | Nor, | NA |
| 4798- | Lyco, | Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence |
| - | Review, | Var, | NA |
| 4790- | Lyco, | Role of Lycopene in the Control of ROS-Mediated Cell Growth: Implications in Cancer Prevention |
| - | Review, | Var, | NA |
| 1710- | Lyco, | Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases |
| - | Review, | CardioV, | NA |
| 1712- | Lyco, | Lycopene Protects against Smoking-Induced Lung Cancer by Inducing Base Excision Repair |
| - | in-vitro, | Lung, | A549 |
| 1713- | Lyco, | Lycopene: A Potent Antioxidant with Multiple Health Benefits |
| - | Review, | Nor, | NA |
| 1715- | Lyco, | Pro-oxidant Actions of Carotenoids in Triggering Apoptosis of Cancer Cells: A Review of Emerging Evidence |
| - | Review, | Var, | NA |
| 2540- | M-Blu, | Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 2533- | M-Blu, | PDT, | Methylene blue-mediated photodynamic therapy enhances apoptosis in lung cancer cells |
| - | in-vitro, | Lung, | A549 |
| 8504- | MAG, | Magnolol nanoparticles combat MRSA by disrupting TCA cycle and arginine metabolism to induce oxidative stress |
| - | in-vitro, | Var, | NA |
| 4517- | MAG, | Mitochondrion-targeted magnolol derivatives exert synergistic anticancer activity by modulating energy metabolism and tumor microenvironment |
| - | vitro+vivo, | Var, | NA |
| 2450- | Matr, | The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors |
| - | Review, | Var, | NA |
| 8559- | Matr, | Matrine induces toxicity in mouse liver cells through an ROS-dependent mechanism |
| - | vitro+vivo, | Nor, | NA |
| 8532- | Matr, | Matrine induction of reactive oxygen species activates p38 leading to caspase-dependent cell apoptosis in non-small cell lung cancer cells |
| - | in-vitro, | NSCLC, | NA |
| 8544- | Matr, | Matrine in Liver Diseases: Mechanistic Insights and Therapeutic Potential |
| - | Review, | BC, | NA |
| 7824- | MBS, | IVT, | VT, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 8627- | MBZ, | Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death |
| - | in-vitro, | CRC, | HT-29 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 8628- | MBZ, | Mebendazole induces apoptosis and inhibits migration via the reactive oxygen species-mediated STAT3 signaling downregulation in non-small cell lung cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 8630- | MBZ, | Rad, | Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism |
| - | in-vitro, | GBM, | GL261 | - | in-vitro, | GBM, | GBM14 |
| 8635- | MBZ, | The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma |
| - | vitro+vivo, | Melanoma, | NA |
| 8637- | MBZ, | Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors |
| - | Trial, | MB, | NA |
| 8652- | MBZ, | Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors |
| - | vitro+vivo, | GBM, | GL-15 |
| 8650- | MBZ, | Autophagy Is a Potential Target for Enhancing the Anti-Angiogenic Effect of Mebendazole in Endothelial Cells |
| - | in-vitro, | Var, | NA |
| 2486- | mCHEMO, | capec, | Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases |
| - | Case Report, | HCC, | NA |
| 2487- | mCHEMO, | Metronomic Chemotherapy: Possible Clinical Application in Advanced Hepatocellular Carcinoma |
| - | Review, | HCC, | NA |
| 8793- | mCHEMO, | Metronomic Chemotherapy in Breast Cancer as a Strategy to Deliver More Sustainable and Less Toxic Treatments: Time to Debunk the Myth? |
| - | Review, | Var, | NA |
| 8786- | mCHEMO, | Metronomic chemotherapy in cancer treatment: new wine in an old bottle |
| - | Review, | Var, | NA |
| 8791- | mCHEMO, | Real-World Efficacy of Metronomic Chemotherapy in Advanced Breast Cancer Across Molecular Subtypes |
| - | Trial, | BC, | NA |
| 8792- | mCHEMO, | Early capecitabine metronomic chemotherapy improves patient prognosis and safety in early-stage triple-negative breast cancer |
| - | Trial, | BC, | NA |
| 8812- | MCP, | Investigation of Antitumor Activity of Modified Citrus Pectin: Oral and Intravenous Administration Assessed via Molecular Imaging |
| - | vitro+vivo, | Ovarian, | SKOV3 | - | in-vitro, | GC, | MKN-28 | - | in-vitro, | BC, | 4T1 |
| 8623- | MCT, | The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis |
| - | Review, | AD, | NA |
| 2643- | MCT, | Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism |
| - | Review, | Nor, | NA |
| 2644- | MCT, | The Effects of Medium-Chain Triglyceride Oil Supplementation on Endurance Performance and Substrate Utilization in Healthy Populations: A Systematic Review |
| - | Review, | Nor, | NA |
| 3905- | MCT, | Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies |
| - | Review, | AD, | NA |
| 3903- | MCT, | Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer’s disease |
| - | Case Report, | AD, | NA |
| 8714- | MeJa, | Methyl jasmonate binds to and detaches mitochondria-bound hexokinase |
| - | in-vitro, | Colon, | CT26 |
| 1899- | MeJa, | Methyl jasmonate induces production of reactive oxygen species and alterations in mitochondrial dynamics that precede photosynthetic dysfunction and subsequent cell death |
| - | in-vitro, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid